It may go down 30-40% but will not close down to 40%. Novogen is now cashed up with two great potentials drugs on table that could make a hisotry if succcessful. Nasdaq act lot differently than ASX where global cashed up investors looking for a junior bio like Novogen that can bring great return in medium-long term. This will be soaked up at such a great discounted price.
Cheer
J
Nasdaq 21/4, page-2
-
- There are more pages in this discussion • 98 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)